Pfizer Phase 1 – 2 Trial Data on RSV Vaccine Candidate

Dr. Phil Dormitzer, VP and CSO, Viral Vaccines at Pfizer Vaccines Research and Development discusses the significance of new data presented at the 2019 IDWeek conference for a respiratory syncytial virus  (RSV) vaccine candidate. The vaccine is currently in Phase 2b trials in pregnant women in the United States and the Phase 1/2 data being presented at IDWeek show encouraging safety and immune response. No vaccine is currently licensed for use specifically in pregnant women to protect infants.

Read More

Bipolar Disorder – A New Treatment Option

Dr. Gustavo Alva, psychiatrist, discusses mood episodes, such as depression, mixed episodes, and mania, why diagnosing bi-polar disorder remains challenging and complex, and a new option for treating bi-polar depression which can streamline a treatment decision.  Interview on behalf of Allergan.

Read More

Coping with Overactive Bladder

Stacy Kaiser, celebrity psychotherapist, discusses coping with medical issues such as overactive bladder (OAB).  She talks about “Coping Confessions” a new campaign sponsored by Astellas that sheds light on when coping has gone too far and is unproductive and how to take action to prevent coping from ruling our lives.

Read More

KEYTRUDA Phase 3 KEYNOTE-522 Trial Data

Dr. Jonathan Cheng with Merck Research Laboratories discusses  data presented at the European Society for Medical Oncology (ESMO) 2019 Congress on the phase 3 KEYNOTE-522 trial of Merck’s KEYTRUDA® plus chemotherapy in early-stage triple-negative breast cancer.

Read More

ESMO 2019 PAOLA Trial

Returning guest Dr. Scot Ebbinghaus with Merck Research Labs discusses positive data presented at the European Society for Medical Oncology (ESMO) 2019 Congress on the phase 3 PAOLA-1 trial of Merck and AstraZeneca’s LYNPARZA® (olaparib) added to Bevacizumab for newly diagnosed advanced ovarian cancer

Read More

ESMO 2019 PROfound Trial

Returning guest Dr. Scot Ebbinghaus with Merck Research Labs discusses data presented at the European Society for Medical Oncology (ESMO) 2019 Congress on the phase 3 PROfound trial of Merck and AstraZeneca’s LYNPARZA® (olaparib) evaluating a targeted treatment in biomarker-selected metastatic castration-resistant prostate cancer patients.

Read More

The Zephyr Endobronchial Valve – Spectrum Health

Dr. Gustavo Cumbo-Nacheli, board-certified interventional pulmonologist talks about the Zephyr® Endobronchial Valve, a small umbrella-like object placed in the airway with a camera scope.  This new device is made by Pulmonx, was approved by the FDA in 2018 and is helping patients with COPD and Emphysema live better, healthier lives.

Read More